top of page

FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy July 21, 2025

2025

Duration:

00:07:26

Year:

DAVID HEALY FDA PANEL SSRIS PREGNANCY
DAVID HEALY FDA PANEL SSRIS PREGNANCY

This is a short presentation at an FDA panel on SSRIs in pregnancy - it covers the risk of Autistic Spectrum Disorder. The FDA Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy took place on July 22, 2025.

2025

Duration:

01:57:53

Year:

FDA EXPERT PANEL ON SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND PREGNANCY
FDA EXPERT PANEL ON SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND PREGNANCY

The FDA Expert Roundtable on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy will facilitate discussions on the safety of the developing child. Participants include: Anick Berard; Jay Gingrich; Jeffrey Lacasse; Michael Levin; Roger McFillin; Joanna Moncrieff; Adam Urato and Josef Witt-Doerring.

2025

Duration:

00:05:49

Year:

DR. ROGER MCFILLIN FDA EXPERT PANEL ON SELECTIVE SEROTONIN REUPTAKE INHIBITORS
DR. ROGER MCFILLIN FDA EXPERT PANEL ON SELECTIVE SEROTONIN REUPTAKE INHIBITORS

"If you want to increase suffering, you fundamentally get people to battle their own internal experiences. You learn not to trust your emotions, you judge them as symptoms." We are facing an epidemic of iatrogenic harm. Manufacturing a disease to sell more drugs. There are better ways.

Warning

 

The most extreme reactions to antidepressants, including suicide and violence, are more common when the dosage of an antidepressant changes or when starting or discontinuing the medication. Sometimes these reactions are caused by switching from one type of antidepressant to another. Anyone considering altering the dosage of their medication or withdrawing from it should take medical advice first from a doctor or suitably qualified practitioner. Some doctors are unaware of these issues so you may need to find one who recognises the problems and can support you.

 

Although some of our contributors and team members may work as practitioners, all of the final editorial decisions related to the content of this website have been made by non-medical people and are provided for general educational purposes only. None of the information and resources on the Antidepressant Risks website or provided in any communication constitutes or should be seen as medical, mental health, counselling, clinical or professional advice of any kind. For a full copy of our disclaimer please click here.

contact@antidepressantrisks.org

Antidepressantrisks

Antidepressant Risks CIC

Registered in England and Wales. Company No: 17402838

© Antidepressant Risks 2021-2026

United Kingdom

Disclaimer 

bottom of page